Chief Financial Officer
CurrentBioCardia is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular disease. Its lead therapeutic candidate is the CardiAMP cell therapy system for heart failure. The Company has two enabling device product lines: the Helix biotherapeutic delivery system (“Helix”) product line offers a catheter system for the local.